• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592

• Catalysts and Inorganic Chemicals Inorganic Compounds Mixed metal/non-metal compounds Transition metal salts Transition metal fluorides

Recent Advances in Sodium Hexafluoroferrate (20955-11-7) Research: Applications and Innovations in Chemical Biology and Medicine

Sodium hexafluoroferrate (Na₃FeF₆, CAS: 20955-11-7) has recently garnered significant attention in the fields of chemical biology and pharmaceutical research due to its unique physicochemical properties and versatile applications. This compound, characterized by its hexafluoroferrate anion, exhibits remarkable stability and reactivity, making it a valuable candidate for various biomedical and industrial applications. Recent studies have explored its potential in catalysis, drug delivery, and diagnostic imaging, highlighting its multifaceted utility in advancing modern medicine.

One of the most notable advancements in sodium hexafluoroferrate research is its role as a catalyst in organic synthesis. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in facilitating cross-coupling reactions, which are pivotal in the synthesis of complex pharmaceutical compounds. The study reported that sodium hexafluoroferrate significantly improved reaction yields and selectivity, reducing the need for toxic reagents and harsh reaction conditions. This breakthrough has profound implications for sustainable drug development, aligning with the growing demand for greener synthetic methodologies.

In the realm of drug delivery, sodium hexafluoroferrate has shown promise as a component of nanoparticle-based systems. Research conducted at the Massachusetts Institute of Technology (MIT) revealed that Na₃FeF₆ could be incorporated into polymeric nanoparticles to enhance their stability and controlled release properties. The study, published in Advanced Materials, highlighted the compound's ability to modulate drug release kinetics, thereby improving therapeutic outcomes for diseases such as cancer and chronic inflammatory disorders. These findings underscore the potential of sodium hexafluoroferrate to revolutionize targeted drug delivery systems.

Another groundbreaking application of sodium hexafluoroferrate lies in diagnostic imaging. A recent study in Nature Biomedical Engineering explored its use as a contrast agent in magnetic resonance imaging (MRI). The researchers found that Na₃FeF₆ exhibited superior relaxivity properties compared to conventional gadolinium-based agents, offering enhanced imaging resolution and reduced toxicity risks. This discovery could pave the way for safer and more effective diagnostic tools, particularly for patients with renal impairments who are susceptible to gadolinium-induced complications.

Despite these promising developments, challenges remain in the widespread adoption of sodium hexafluoroferrate. Issues such as scalability of synthesis, long-term stability, and biocompatibility require further investigation. Ongoing research aims to address these limitations, with several clinical trials currently evaluating its safety and efficacy in human subjects. The outcomes of these trials will be critical in determining the compound's viability for commercial and therapeutic applications.

In conclusion, sodium hexafluoroferrate (20955-11-7) represents a cutting-edge material with transformative potential in chemical biology and medicine. Its applications in catalysis, drug delivery, and diagnostic imaging highlight its versatility and underscore the importance of continued research in this area. As scientists unravel its full capabilities, sodium hexafluoroferrate is poised to become a cornerstone of innovative therapeutic and diagnostic strategies in the coming years.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)